from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2925c/rnc

LFCtreatmentdescriptionclass of inhibitor

0.432

Amikacinug/mL Amikacintranslation

0.128

Cap5-10ug/mL Capreomycintranslation

0.220

Rox10-50 ug/mL Roxithromycintranslation

0.171

SM2-5 ug/mL Streptomycintranslation

0.778

Tet5-10 ug/mL Tetracyclinetranslation

-0.249

Rif0.2-5ug/mL Rifampicintranscription

-1.015

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.541

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.116

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.554

CPZ10-50 ug/mL Chlorpromazinerespiration

0.774

Clofazimine10-13 ug/mL Clofaziminerespiration

0.212

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.608

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.055

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.701

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.138

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.150

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.726

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.397

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.424

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.891

KCN5-20 ug/mL Potassium cyaniderespiration

0.613

NaN30.2-2 mM Sodium aziderespiration

0.473

Nigericin50 uM Nigericinrespiration

0.761

TRC10-150 ug/mL Triclosanrespiration

1.526

TRZ10-25 ug/mL Thioridazinerespiration

0.403

Valinomycin0.5-10 uM Valinomycinrespiration

-0.671

ZnSO42 mM ZnSO4respiration

0.125

menadione6-10 ug/mL Menadionerespiration

-0.113

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.790

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.245

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.600

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.473

NRP_1Non-replicating persistence stage 1dosRassociated

-0.343

Amp0.2mg/mL AmpicillincellWall

-0.317

Cephalexin20-100 ug/mL CephalexincellWall

-0.576

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.261

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.269

EMB10-20 ug/mL EthambutolcellWall

-0.118

Eta12-40 ug/mL EthionamidecellWall

-0.046

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.266

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.664

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.560

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.263

BZA0.12 mg/mL BenzamidearomaticAmides

-0.316

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.426

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.125

H2O24 mM hydrogen peroxideDNAdamaging

-0.027

Levo10 ug/mL LevofloxacinDNAdamaging

-0.998

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.597

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.144

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.675

UVUV-irradiationDNAdamaging

0.229

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.476

Antimycin12.5-50 ug/mL Antimycin A?

-0.540

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.021

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.097

PA8240.2-2 ug/mL PA-824?

1.139

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.367

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.426

Verapamil50 uM Verapamil?

-0.218

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.301

methoxatin10-20 ug/mL Methoxatin?